This content is protected - please log in with your customer account to continue.
Reset your password
We will send you an email to reset your password
Login
If you have an account with us, please log in.
Welcome to Prime BioGroup!
This content is protected - please log in with your customer account to continue.
We will send you an email to reset your password
If you have an account with us, please log in.
Orders placed by 6:00PM ship the next business day.
Orders are shipped Monday through Thursday only.
Most orders are processed and shipped within 1 business day after being placed.
We do not ship on Fridays, weekends, or federal holidays to prevent packages from being held in transit.
Monday - Thursday
8:30am - 3:00pm MST
Your cart is currently empty.
Not sure where to start? Try these collections:
Vendor: Prime Peptides
Out of stock
Larazotide acetate (formerly AT-001, Alba Therapeutics) is an oral peptide derived from the zonula occludens toxin secreted by Vibrio Cholera. As a tight junction regulator, it binds to receptors of apical intestinal cells and prevents opening of epithelial intestinal tight junctions induced by bacterial antigens, pro-inflammatory cytokines, or gliadin peptides. Its mechanism has been supported by in vitro and in vivo studies, making it a suitable candidate to treat celiac disease.
Larazotide acetate aids in the restoration of the intestinal barrier function by intervening in the zonulin-mediated signaling pathway, blocking zonulin receptors, preventing tight junction disassembly, and minimizing the increase in intestinal permeability. Moreover, larazotide acetate is involved in rearranging several tight junction proteins to promote tight junction assembly. Larazotide acetate also plays a role in stimulating tight junction closure.
BOTTLE DESIGN MAY VARY
